P1191 Aims: In order to investigate the function of pancreatic islets transplantation in allogeneic and xenogeneic large animal models, induction of diabetes mellitus is needed. In this experimental study, we searched the most appropriate tool for induction of diabetes in both pig and primate models: Streptozotocin (STZ) or total pancreatectomy (TP). Methods: In juvenile pigs (20 weeks), multiple (2-3) low doses STZ (40mg/kg iv, n=4), one high dose STZ (150mg/kg iv, n=9) and total pancreatectomy (n=3) were tested to induce diabetes. Two different intravenous STZ doses were tested in Cynomolgus monkeys (50mg/kg (n=5) vs. 135mg/kg (n=2)). Hepatic enzymes (AST, ALT), renal function (creatinine), intra-venous glucose tolerance test (IVGTT: Area under the curve, AUC), non-fasting blood glucose and animal weight were assessed prior to, one and 4 weeks after diabetes induction. Beta cell destruction was evaluated by immunohistochemistry with insulin staining and non-beta cells by somatostatin, glucagon and pancreatic polypeptide staining. Results: Single or multiple low doses of STZ did not induce diabetes or side-effects in four in juvenile pigs (normal AST, ALT and creatinine). The three pigs which underwent TP became rapidly and definitively (4-5 days) hyperglycaemic and polyuric. Total pancreatectomy provoked an irreversible and pathological IVGTT (AUC: 45,513 ± 3,021 mg/dl/min) as compared to controls (n=9) (8,094 ± 1,902 mg/dl/min) (p<0.005). Similarly, one high dose STZ induced in pigs a significantly pathological IVGTT after one week (n=5) (32,134 ±7,037 mg/dl/min) (p<0.05). Four weeks after one high dose STZ injection, however, a significant decrease of AUC calculated after IVGTT was observed in six pigs tested (20,562±7,261 mg/dl/min) (p<0.005), thereby suggesting the survival or regeneration of beta cells. In fact, all the pancreas from STZ-treated pigs analysed after 4 weeks demonstrated the presence of small beta cells located at distance of vascular structure (co-staining insulin/von Willebrand factor). Moreover, a significant beta cellular hypertrophy could be evidenced between one and 4 weeks after STZ (98±7 μm2 vs. 120±12μm2) (p<0.05). Last but not least, a clear ductal-beta cell transdifferentiation (co-staining insulin/cytokeratin 19) was broadly observed in pancreas harvested 4 weeks after STZ. Cynomolgus treated with high dose STZ (135mg/kg (n=2) rapidly demonstrated an increase of hepatic enzymes (>200 IU/l)) and creatinine (>6mg/dl) due to liver steatosis and kidney tubular necrosis. These animals eventually died within two weeks after injection. Low dose of STZ (55mg/kg) induced an increase of non-fasting blood glucose (>200mg/dl), a pathological IVGTT (AUC: 5,534±747 mg/dl/min) as compared with untreated animals (13,005±3,084 mg/dl/min) (p<0.05). This STZ regimen did not induce any hepatic or renal deterioration and no residual serum C-peptide could be detected. In these animals, pathological IVGTT was confirmed 3 months after low dose STZ injection and the insulin-deficient state could be related to massive amyloid polypeptide deposits in islets. Conclusions: Low-dose STZ successfully induces irreversible diabetes in monkeys but not in young pigs. High dose STZ induces transient hyperglycaemic state in pigs but no irreversible diabetes due to a hypertrophy of beta cells and ductal transdifferentiation. This result suggests that high dose STZ could be used as a model of “in vivo” ductal differentiation. In juvenile pigs, TP seems to be the only choice for diabetes induction model for studying pig islets transplantation.
Read full abstract